Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers
Open Access
- 1 January 1995
- journal article
- conference paper
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 21 (1), 71-81
- https://doi.org/10.1016/s0741-5214(95)70245-8
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Wound therapy: growth factors as agents to promote healingTrends in Biotechnology, 1993
- Dose Responsive Effects of PDGF-BB, PDGF-AA, EGF, and bFGF on Granulation Tissue in a Guinea Pig Partial Thickness Skin Excision ModelGrowth Factors, 1993
- Management of Diabetic Midfoot UlcersAnnals of Surgery, 1992
- Platelet-derived growth factor BB for the treatment of chronic pressure ulcersThe Lancet, 1992
- Stimulation of Healing of Chronic Wounds by Epidermal Growth FactorPlastic and Reconstructive Surgery, 1991
- Role of platelet‐derived growth factor in wound healingJournal of Cellular Biochemistry, 1991
- PLATELET-DERIVED GROWTH FACTORThe Lancet, 1989
- The biology of platelet-derived growth factorCell, 1986
- Utility of transcutaneous oxygen tension measurements in peripheral arterial occlusive diseaseJournal of Vascular Surgery, 1984
- The molecular biology of platelet-derived growth factorCell, 1983